Applied DNA Sciences Inc (NASDAQ:APDN), through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox (formerly known as monkeypox). Shares rose some 37% ...
Applied DNA Sciences (NASDAQ:APDN) on Monday announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part of ...
Applied DNA Sciences (APDN) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $5.20 per share a year ago. These figures ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Applied DNA Sciences ( (APDN)) has ...
Applied DNA Sciences has received a new U.S. patent set to strengthen the company’s cotton genotyping and traceability portfolio. The Stony Brook, N.Y.-based company said the patent protects its ...
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company focused on providing nucleic acid production solutions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results